Target intelligence / Profile preview

Pathogenic bacteria surface structures

Molecular classification
Polysaccharide, Protein, Lipid, Peptidoglycan, Glycoprotein
01

Overview

Pathogenic bacteria surface structures represent a broad category of extracellular and cell-envelope components that are critical for bacterial survival, pathogenesis, and host interaction [1]. These structures include the peptidoglycan cell wall, the outer membrane of Gram-negative bacteria (containing lipopolysaccharides), capsules, pili (fimbriae), and flagella [1, 3]. Biologically, they provide structural rigidity, facilitate motility, and enable the bacteria to adhere to host tissues or evade immune detection through mechanisms like antigenic variation or physical shielding [1]. Because many of these structures are unique to prokaryotes, they are primary targets for antimicrobial therapy; for example, beta-lactam antibiotics and glycopeptides like vancomycin target peptidoglycan synthesis, while polymyxins target the lipopolysaccharide (LPS) layer [2]. Furthermore, surface polysaccharides and proteins serve as the basis for many conjugate and recombinant vaccines, which prime the host immune system to recognize and neutralize specific pathogens [4]. However, the diversity and rapid evolution of these surface components present significant challenges, including the development of multi-drug resistance and the potential for systemic inflammatory responses, such as sepsis, upon the release of endotoxins during bacterial lysis [3]. Citations: [1] Silhavy, T. J., et al. (2010) Cold Spring Harb Perspect Biol. [2] Bush, K., & Bradford, P. A. (2016) Cold Spring Harb Perspect Med. [3] Ramachandran, G. (2014) Virulence. [4] Rappuoli, R. (2018) EMBO Mol Med.

Other names
Bacterial cell envelopeSurface antigensCell wall componentsPathogen-associated molecular patterns (PAMPs)Extracellular matrix-binding proteins
02

Mechanism of action

Inhibition of cell wall peptidoglycan synthesis, disruption of the outer membrane or cytoplasmic membrane integrity, and induction of antibody-mediated opsonization or neutralization of surface antigens [2, 4].

03

Biological functions

Cellular structural integrityAdhesionMotilityImmune evasionNutrient transport
04

Disease associations

InfectionSepsisInflammation
05

Safety considerations

Antibiotic resistanceJarisch-Herxheimer reactionEndotoxin release leading to septic shockMicrobiome dysbiosis
06

Interacting drugs

Penicillin

6 more in the full profile.

07

Biomarkers

ProcalcitoninC-reactive proteinBacterial surface antigens (e.g., O-antigens, K-antigens)Bacterial DNA

Beyond the preview

Go deeper on Pathogenic bacteria surface structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacteria surface structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call